Skip to main content

15 October 2025

Last updated: Wednesday 15 October 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Alternative funding strategies for biotech

Saturday 25 July 2009

Interviewee/Contributor

Michael Nowak

Organisation

Yorkville Advisors

Organisations

TiGenix NV
Marks and Clerk LLP
Shore Capital
Edmond de Rothschild Partners
Novasecta Ltd
Allergy Therapeutics Plc
Artios Pharma Ltd
Kymab Ltd
ICON P&MA
The Pioneer Group

Interviewees and Contributers

Brian Edwards
Priya Kalia and Miranda Weston-Smith
Richard Jones and Stephen Witte
Bahija Jallal
Stéphane Degove
Gwen Melincoff
Dr Richard Jarman
Jonathan D Moore
Oliver Rausch
Frederic Triebel

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

CHARM Therapeutics appoints CMO

Tuesday 16 September 2025

Abzena appoints CEO

Tuesday 16 September 2025

OMass Therapeutics appoints director

Tuesday 16 September 2025

Maxion Therapeutics appoints non-executive director

Tuesday 16 September 2025

AlzeCure Pharma appoints head of development

Tuesday 16 September 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form